Cathie Wood’s ARK Offloads Strata Skin Sciences Stock
Cathie Wood’s ARK Investment Management has significantly reduced its exposure to Strata Skin Sciences. Recent trade data confirms that the firm liquidated a portion of its holdings in the medical technology company, a move that has drawn attention from market analysts tracking ARK’s portfolio adjustments. This strategic divestment reflects a broader reshuffling within ARK’s funds as they navigate current volatility in the small-cap healthcare sector.